Human Genome Epidemiology Literature Finder
Records 1 - 17 (of 17 Records) |
Query Trace: Polycythemia Vera and SRSF2[original query] |
---|
Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 359 patients of the AGIMM group. American journal of hematology 2016 Apr . Rotunno Giada, Pacilli Annalisa, Artusi Valentina, Rumi Elisa, Maffioli Margherita, Delaini Federica, Brogi Giada, Fanelli Tiziana, Pancrazzi Alessandro, Pietra Daniela, Bernardis Isabella, Belotti Clara, Pieri Lisa, Sant'Antonio Emanuela, Salmoiraghi Silvia, Cilloni Daniela, Rambaldi Alessandro, Passamonti Francesco, Barbui Tiziano, Manfredini Rossella, Cazzola Mario, Tagliafico Enrico, Vannucchi Alessandro M, Guglielmelli Pao |
Genetic Risk Assessment in Myeloproliferative Neoplasms. Mayo Clinic proceedings 2017 8 92 (8): 1283-1290. Tefferi Ayalew, Vannucchi Alessandro Mar |
Monocytosis in polycythemia vera: Clinical and molecular correlates. American journal of hematology 2017 Mar . Barraco Daniela, Cerquozzi Sonia, Gangat Naseema, Patnaik Mrinal M, Lasho Terra, Finke Christy, Hanson Curtis A, Ketterling Rhett P, Pardanani Animesh, Tefferi Ayal |
Comparison of the Mutational Profiles of Primary Myelofibrosis, Polycythemia Vera, and Essential Thrombocytosis. American journal of clinical pathology 2017 May 147 (5): 444-452. Song Jinming, Hussaini Mohammad, Zhang Hailing, Shao Haipeng, Qin Dahui, Zhang Xiaohui, Ma Zhenjun, Hussnain Naqvi Syeda Mahrukh, Zhang Ling, Moscinski Lynn |
Non-driver mutations in patients with JAK2V617F-mutated polycythemia vera or essential thrombocythemia with long-term molecular follow-up. Annals of hematology 2017 11 97 (3): 443-451. Senín Alicia, Fernández-Rodríguez Concepción, Bellosillo Beatriz, Camacho Laura, Longarón Raquel, Angona Anna, Besses Carles, Álvarez-Larrán Alber |
Targeted molecular characterization shows differences between primary and secondary myelofibrosis. Genes, chromosomes & cancer 2019 7 59 (1): 30-39. Courtier Frédéric, Garnier Séverine, Carbuccia Nadine, Guille Arnaud, Adélaide José, Chaffanet Max, Hirsch Pierre, Paz Damien Luque, Slama Bohrane, Vey Norbert, Ugo Valérie, Delhommeau François, Rey Jérome, Birnbaum Daniel, Murati An |
[The genetic characteristics of BCR-ABL-negative myeloproliferative neoplasms]. Zhonghua nei ke za zhi 2019 12 59 (1): 35-39. Lyu X D, Li Y W, Guo Z, Xin Y P, Hu J Y, Fan R H, Song Y |
Mutational profiling in myelofibrosis: implications for management. International journal of hematology 2019 10 111 (2): 192-199. Bose Prithviraj, Verstovsek Srd |
A case of a primary myelofibrosis with progression and related literature review of progression phase genetics. International journal of laboratory hematology 2021 7 43 Suppl 1 78-81. Chen Dong, Fuda Franklin, Weinberg Ol |
Venetoclax with azacitidine or decitabine in blast-phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases. American journal of hematology 2021 (7): 781-789. Gangat Naseema, Guglielmelli Paola, Szuber Natasha, Begna Kebede H, Patnaik Mrinal M, Litzow Mark R, Al-Kali Aref, Foran James M, Palmer Jeanne M, Alkhateeb Hassan, Elliott Michelle A, Hanson Curtis A, Pardanani Animesh, Mannelli Francesco, Vannucchi Alessandro M, Tefferi Ayal |
Combination of myeloproliferative neoplasm driver gene activation with mutations of splice factor or epigenetic modifier genes increases risk of rapid blastic progression. European journal of haematology 2021 1 106 (4): 520-528. Bartels Stephan, Vogtmann Julia, Schipper Elisa, Büsche Guntram, Schlue Jerome, Lehmann Ulrich, Kreipe Ha |
[Genetic characteristics and prognostic values of RAS mutations in patients with myelofibrosis]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2021 1 41 (12): 989-995. Wu J Y, Li B, Jia Y J, Zhang P H, Xu Z F, Qin T J, Qu S Q, Pan L J, Liu J Q, Yan X, Zhang Y D, Chen J, Gong J Y, Xiao Z |
[Analysis of the effect of gene mutations on the efficacy of ruxolitinib in patients with myelofibrosis based on second-generation sequencing technology]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2022 6 43 (4): 323-329. Tan Y X, Luo J, Huang J X, Luo D M, Liang H Y, Zhou X, Liu X L, Xu |
Lab tests for MPN. International review of cell and molecular biology 2022 2 366 187-220. Moncada Alice, Pancrazzi Alessand |
JAK2V617F variant allele frequency, non-driver mutations, single-nucleotide variants and polycythemia vera outcome. Journal of cancer research and clinical oncology 2022 Oct . Kandu?a Zuzanna, Janowski Micha?, Wi?ckowska Barbara, Paczkowska Edyta, Lewandowski Krzyszt |
The clinical relevance of broad mutational screening of myeloproliferative neoplasms at diagnosis. Frontiers in oncology 2023 8 13 1190305. Helna Pettersson, Jenni Adamsson, Peter Johansson, Staffan Nilsson, Lars Palmqvist, Björn Andréasson, Julia A |
[Clinical characteristics and prognostic factors of patients with Philadelphia-negative myeloproliferative neoplasm accelerated/blast phase]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2023 6 44 (4): 276-283. X Yan, T J Qin, B Li, S Q Qu, L J Pan, F H Li, N N Liu, Z J Xiao, Z F |
- Page last reviewed:Feb 1, 2024
- Content source: